![](/img/cover-not-exists.png)
O3.6 * Combination of HSP90 inhibitor onalespib with crizotinib to treat or delay resistance in NSCLC: Preclinical and Clinical Investigations
Keer, H., Smyth, T., Courtin, A., Hearn, K., Lyons, J., Wallis, N., Oganesian, A., Azab, M.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv081.6
Date:
March, 2015
File:
PDF, 28 KB
english, 2015